Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Undefined-antigen vaccines.

Hong-Ming Hu¹, Yiwei Chu, Walter J Urba

¹Laboratory of Cancer Immunobiology, Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Portland Medical Center, Portland, Oregon, USA.

Cancer Treatment and Research

|October 11, 2005

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A tailored in vivo CRISPR screen identifies BAP1 as a potent tumor suppressor of sarcoma.

JCI insight·2026

Same author

Early evidence of the efficacy of TCR-T therapy targeting the G12V mutation in patients with advanced pancreatic cancer.

Molecular therapy : the journal of the American Society of Gene Therapy·2026

Same author

Targeting senescent EGR1<sup>+</sup> B cells enhances immunotherapy efficacy in esophageal squamous cell carcinoma.

Cell reports. Medicine·2026

Same author

Liver-specific paraoxonase-1 alleviates regulatory T cell-driven immunosuppression via metabolic reprogramming in hepatocellular carcinoma.

Nature communications·2025

Same author

Oleic acid restores the impaired antitumor immunity of γδ-T cells induced by palmitic acid.

Signal transduction and targeted therapy·2025

Same author

IND-Enabling Studies for a TCR-T Targeting a Pancreatic Cancer KRASG12V Mutation.

Clinical cancer research : an official journal of the American Association for Cancer Research·2025

Same journal

Clinical Trials and Translational Advances in Metabolic Targeting.

Cancer treatment and research·2026

Same journal

Tools and Technologies for Studying Cancer Metabolism.

Cancer treatment and research·2026

Same journal

Cancer and Immune Cells: A Metabolic Battle in the Tumor Microenvironment.

Cancer treatment and research·2026

Same journal

Biomarkers of Cancer Metabolism and Therapeutic Response.

Cancer treatment and research·2026

Same journal

Targeting Metabolism in Cancer Therapy: Inhibitors and Approaches.

Cancer treatment and research·2026

Same journal

Metabolic Reprogramming in Cancer Stem Cells.

Cancer treatment and research·2026

See all related articles

Cancer vaccines combining immunotherapy advances with cellular antigens show promise. While not yet standard, these approaches are well-tolerated and demonstrate immunologic activity, suggesting potential for future effective cancer treatments.

Area of Science:

Immunology
Oncology
Vaccine Development

Background:

Growing understanding of immune system-tumor cell interactions fuels novel cancer treatment strategies.
Recent decades have seen numerous advances in basic science applicable to cancer therapy.

Purpose of the Study:

To review strategies combining recent scientific advances with cellular antigen preparations for cancer vaccine development.
To assess the efficacy and tolerability of these experimental cancer vaccine approaches.

Main Methods:

Review of various strategies integrating new scientific knowledge with undefined cellular antigen preparations.
Analysis of clinical data regarding patient tolerance, immunologic activity, and clinical outcomes.

Main Results:

Related Experiment Videos

No reviewed cancer vaccine strategies have achieved standard therapy status.
Tested approaches were generally well-tolerated in patients with advanced cancer.
Evidence of significant immunologic activity and clinical responses across diverse malignancies was observed.

Conclusions:

Current experimental cancer vaccines, despite limitations, show encouraging safety and biological activity.
These strategies serve as foundational elements for developing more effective future cancer treatments.
Further research and integration of new advances hold potential for successful cancer vaccine development.